Trial Profile
Effect of food on the oral bioavailability of sacubitril/valsartan (LCZ696) in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Essential hypertension; Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis Pharma
- 05 Nov 2016 New trial record
- 10 Oct 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics